SCHEMBL1387208

SCHEMBL1387208

CCNC(=O)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29893277 0.97 ALDH1A1 (0.54)
SCHEMBL2887269 0.82 ALDH1A1 (0.56)
SCHEMBL22694513 0.81
SCHEMBL25487082 0.81
SCHEMBL865926 0.80
SCHEMBL993779 0.79 EPHX1 (0.69)
SCHEMBL23135536 0.79 EPHX1 (0.38)
Bromobenzene SCHEMBL27807093 0.79 KDM4E (0.43)
SCHEMBL467536 0.79 CA3 (0.67)
SCHEMBL589965 0.79 ALDH1A1 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240372141-A1 ELECTROLYTE FOR SECONDARY BATTERY AND SECONDARY BATTERY INCLUDING SAME MICROVAST, INC. 2024-11-07 US claimed
CN-103189373-A Substituted triazolopyridines BAYER IP GMBH 2013-07-03 CN claimed
CN-1759118-B Diazepinoindole derivatives as kinase inhibitors PFIZER 2010-12-08 CN claimed
CN-101107249-B purine derivatives as A2A receptor agonists NOVARTIS AG 2010-10-13 CN claimed
CN-101360714-A Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies ASTRAZENECA AB (SE) 2009-02-04 CN claimed
CN-101360716-A Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia ASTRAZENECA AB (SE) 2009-02-04 CN claimed
CN-1326858-C tricyclic spiropiperidine compounds ASTRAZENECA AB (SE) 2007-07-18 CN claimed
CN-1274685-C Benzimidazol derivatives modulate che mokine receptors ASTRAZENECA AB (SE) 2006-09-13 CN claimed
CN-1759118-A Diazepinoindole derivatives as kinase inhibitors PFIZER (US) 2006-04-12 CN claimed
CN-1229343-C Novel compounds ASTRAZENECA AB (SE) 2005-11-30 CN claimed
EP-0752986-B1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LTD (GB) 1999-05-19 EP claimed
US-5861401-A TREATMENT OF CONGESTIVE HEART FAILURE ZENECA LIMITED (GB) 1999-01-19 US claimed
CN-1190395-A Substituted (sulfonic, sulfinic, sulfonamido or sulfonamido) N- [ aminoiminomethyl) phenylalkyl ] -azaheterocyclic amide compounds RHONE POULENC RORER PHARMA (US) 1998-08-12 CN claimed
EP-0832082-A1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1998-04-01 EP claimed
JP-H09510987-A 1997-11-04 JP claimed
US-5641793-A POSSESS ENDOTHELIN RECEPTOR ANTAGONIST ACTIVITY; USEFUL IN TREATMENT OF HYPERTENSION, CARDIAC OR CEREBRAL CIRCULATORY DISEASE AND RENAL DISEASE ZENECA LIMITED (GB) 1997-06-24 US claimed
EP-0752986-A1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1997-01-15 EP claimed
WO-1996040681-A1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1996-12-19 WO claimed
EP-0682016-A1 Pyridine derivatives ZENECA LIMITED (GB) 1995-11-15 EP claimed
WO-1995026957-A1 N-HETEROCYCLYL SULPHONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1995-10-12 WO claimed